• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH COAGULATION FACTOR VIII DEFICIENT PLASMA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH COAGULATION FACTOR VIII DEFICIENT PLASMA Back to Search Results
Catalog Number OTXW17 SMN 10446411
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/02/2017
Event Type  malfunction  
Manufacturer Narrative
The customer contacted the siemens customer care center questioning the higher results obtained on the bcs xp relative to other non-siemens systems.Siemens headquarters support center (hsc) representatives have evaluated the information provided.Hsc concluded that review of all available information gives no indication of a systemic issue with the bcs xp system, reagent material, or laboratory practices at the customer laboratory.Routine quality control as well as prior survey samples recover acceptably.An overall problem with the fviii % activity application with actin fsl on the bcs xp system can be excluded.Patient comparisons have been conducted and demonstrate acceptable comparison for fviii % activity between the alternate vendor methods (non-siemens).Recovery of the samples fviii % activity on an alternate instrument system with actin fsl reagent and factor viii deficient plasma also was consistent with the bcs xp system recovery.Additionally, comparison across various lots of actin fsl compare well.Comparison of multiple external quality assessment survey vendor samples do not demonstrate a systemic bias.A clear difference in recovery with this specific sample is demonstrated between the application of siemens fviii with actin fsl on the bcsp xp as compared to competitors systems.The patient had received helixate fs product (recombinant factor viii concentrate) prior to collection of this sample.The recovery with siemens products is believed to be accurate for the sample provided to the laboratory for analysis.A false low bias is believed to be demonstrated with the alternate vendor products.The customer has confirmed that no irreparable harm was caused to the patient based upon the original value reported.The device is performing within specifications.No further evaluation of the device is required.
 
Event Description
A factor viii (fviii) result on a patient sample was questioned as discordant relative to values obtained with alternate reagent methodologies.The sample was tested with coagulation factor viii deficient plasma using the dade actin fsl reagent on the bcs xp instrument.The same sample was sent to alternate laboratories for testing.Lower results were obtained with two alternate non-siemens methodologies on non-siemens instruments.The physician questioned the initial fviii results with the siemens system as discordant with the clinical presentation.Patient did receive fviii concentrate four hours before the testing for fviii was performed.There is no indication that patient treatment was altered or prescribed on the basis of the questioned as discordant fviii result.There was no report of adverse health consequences as a result of the questioned as discordant fviii result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGULATION FACTOR VIII DEFICIENT PLASMA
Type of Device
COAGULATION FACTOR VIII DEFICIENT PLASMA
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil von behring strasse 76
marburg, D-350 41
GM  D-35041
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil von behring strasse 76
marburg, D-350 41
GM   D-35041
Manufacturer Contact
james morgera
glasgow business community
500 gbc drive po box 6101
newark, DE 19714-6101
3026318356
MDR Report Key6376100
MDR Text Key69017056
Report Number9610806-2017-00028
Device Sequence Number1
Product Code GJT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K924396
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial
Report Date 03/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/18/2018
Device Catalogue NumberOTXW17 SMN 10446411
Device Lot Number547633
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/02/2017
Initial Date FDA Received03/03/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/06/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-